The AR positivity rate in triple-negative PLC cases in the present study (92.8%) was clearly higher than that previously reported in triple-negative invasive carcinoma of NST, which ranged from 17.7% to 41% [35–39]. This evidence concerns the gene AR and invasive carcinoma.